Product Images Lacosamide
View Photos of Packaging, Labels & Appearance
- 100 mg/10 mL Lacosamide Oral Solution Cup Lid - 100 mg 10 mL Lacosamide Oral Solution Cup Lid
- 200 mg/20 mL Lacosamide Oral Solution Cup Lid - 200 mg 20 mL Lacosamide Oral Solution Cup Lid
- 50 mg/5 mL Lacosamide Oral Solution Cup Lid - 50 mg 5 mL Lacosamide Oral Solution Cup Lid
- Lacosamide Oral Solution USP, 10 mg/mL Label - Label
- Figure 1 - Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose - lacosamide fig1
- Figure 2 - Proportion of patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4 - lacosamide fig2
- Figure 3 - Kalpan-Meier Analysis of Time to 2nd PGTC Seizure (Study 5) Analysis Set: Modified Full Analysis Set - lacosamide fig3
- Structural Formula - lacosamide str
Product Label Images
The following 8 images provide visual information about the product associated with Lacosamide NDC 60687-847 by American Health Packaging, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
100 mg/10 mL Lacosamide Oral Solution Cup Lid - 100 mg 10 mL Lacosamide Oral Solution Cup Lid
This is a prescription medication for Lacosamide oral solution, USP with a concentration of 100 mg/10 mL. The solution includes Phenylalanine 0.14 mg and is suitable for individuals with phenylketonuria. The text also contains product identification codes such as NDC60687-847-02 and indicates that it delivers 10 mL.*
200 mg/20 mL Lacosamide Oral Solution Cup Lid - 200 mg 20 mL Lacosamide Oral Solution Cup Lid
50 mg/5 mL Lacosamide Oral Solution Cup Lid - 50 mg 5 mL Lacosamide Oral Solution Cup Lid
This label provides information on Lacosamide A in oral solution form with a concentration of 50 mg per 5 mL. The solution contains Phenylalanine at a concentration of 0.07 mg. It is important not to freeze the solution. For full prescribing information and storage instructions, refer to the package insert. This product is intended for institutional use only and is distributed by American Health Packaging.*
Lacosamide Oral Solution USP, 10 mg/mL Label - Label
This is a description for Lacosamide (V) Oral Solution, USP. It is a prescription drug intended for institutional use only. The solution contains 10 mg of lacosamide USP per mL. It is important to dispense it with the accompanying Medication Guide to each patient. This solution should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It should not be frozen.*
Figure 1 - Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose - lacosamide fig1
The text provides a figure showing the Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase for different doses in Studies 2, 3, and 4. It includes data comparing the reduction in seizure frequency with Lacosamide and Placebo at varying dose levels. Study results and statistically significant differences are mentioned.*
Figure 2 - Proportion of patients by Responder Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4 - lacosamide fig2
Figure 3 - Kalpan-Meier Analysis of Time to 2nd PGTC Seizure (Study 5) Analysis Set: Modified Full Analysis Set - lacosamide fig3
This text describes a Kalpan-Meier Analysis of Time to 2" PGTC Seizure for Study 5, with the analysis set as the Modified Full Analysis Set. The figure illustrates data on patients still at risk in the study at different time points. The numbers at the bottom of the figure represent the patients continuing in the study without an event or censoring before the specified timepoint.*
Structural Formula - lacosamide str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
